Carcinoma: all 6,718 studies
Page 42 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.
- High Dose IL 2 and Entinostat in RCCActive, not recruitingNCT03501381Phase 2
- Phase 1b of ASLAN001 (Varlitinib) in Patients With Advanced/ Metastatic Hepatocellular Carcinoma (HCC)Status unknownNCT03499626Phase 1/2
- Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT03498378Phase 1
- Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation TherapyCompletedNCT03493789Phase 1
- Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine TestStatus unknownNCT03493763
- Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell CarcinomaNo longer availableNCT03492489
- Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver TransplantationCompletedNCT03490461
- Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell CarcinomaStatus unknownNCT03486509Phase 2
- Intraoperative Detection of Residual BCC by Fast RamanStatus unknownNCT03482622
- Electronic Cigarette Use During PregnancyCompletedNCT03480373
- R1vascular Hepatectomy for HCC PatientsCompletedNCT03476421
- Prognostic Value of Lymph Node Dissection in Patients With Transitional Cell Carcinoma of the Upper Urinary TractStatus unknownNCT03474926Phase 2
- Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney CancerCompletedNCT03473730Early Phase 1
- Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA PatientsCompletedNCT03473574Phase 2
- Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell CarcinomaCompletedNCT03471897
- Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?CompletedNCT03469596
- BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction CarcinomaCompletedNCT03469557Phase 2
- Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical CancerStatus unknownNCT03469531Phase 2
- Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan CriteriaStatus unknownNCT03469479Phase 3
- Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System NeoplasmsStatus unknownNCT03468244Not applicable
- HAIC of FOLFOX vs. HAIC of OXA for Advanced HCCStatus unknownNCT03468231Phase 3
- Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell CarcinomaCompletedNCT03467789Phase 1
- Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial CarcinomaCompletedNCT03464734Phase 2
- A Study of CaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinomaCompletedNCT03463681Phase 2
- T-VEC in Non-melanoma Skin CancerCompletedNCT03458117Phase 1
- Study in the Treatment of HCC With a Radiopaque (RO) Bead (LC Bead LUMI™) Loaded With DoxorubicinWithdrawnNCT03452553Not applicable
- Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar CancersCompletedNCT03452332Phase 1
- Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCCStatus unknownNCT03450967Phase 2
- Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial)Status unknownNCT03449173Phase 2
- Oncological Outcome of Contralateral Submental Artery Island Flap Versus Primary Closure in Tongue Squamous Cell CarcinomaStatus unknownNCT03440151Not applicable
- A Study of BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaCompletedNCT03433027Phase 2
- Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerTerminatedNCT03432741Phase 1
- Talimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell CarcinomaWithdrawnNCT03430687Phase 1
- Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular CarcinomaCompletedNCT03430635
- PET and MRI in Prognosis Prediction of NPCCompletedNCT03429868Not applicable
- CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell CarcinomaCompletedNCT03427476Phase 1
- Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal CarcinomaCompletedNCT03427359Phase 2
- Apatinib for Advanced Biliary CarcinomaStatus unknownNCT03427242Phase 2
- A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell CarcinomaStatus unknownNCT03424291Phase 2
- Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)CompletedNCT03421912Not applicable
- Efficiency of Presurgical Basal Cell Carcinoma Margin MappingTerminatedNCT03420846Not applicable
- Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell CarcinomaCompletedNCT03419572
- Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder CancerWithdrawnNCT03419130Phase 2
- A Study of Individualized Radiotherapy Based on a Prediction Model of Lymph Node Metastasis in Hepatocellular CarcinomaStatus unknownNCT03416803Not applicable
- Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma PatientsStatus unknownNCT03411954
- Metastatic Breast Carcinoma and Women Sexual Quality of LifeCompletedNCT03408769
- The Clinical Validity and Safety of IOP Injection MRI Contrast Agent in Hepatocellular CarcinomaCompletedNCT03407495Phase 2
- Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter StudyCompletedNCT03405909
- Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 StageStatus unknownNCT03403829Phase 3
- A Study to Investigate The Effectiveness Of Atezolizumab In Patients With Inoperable Locally-Advanced Or Metastatic Urothelial Carcinoma Of The Urinary Tract (Announce)TerminatedNCT03399643
- Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After RadiotherapyCompletedNCT03398980
- Study of Apatinib Combined With TACE in Advance Hepatocellular CarcinomaStatus unknownNCT03398122Not applicable
- Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell CarcinomaTerminatedNCT03393936Phase 1/2
- Nivolumab as Treatment for Recurrent/Metastatic Nasopharyngeal Carcinoma After Failing 2 Lines or More Previous ChemotherapyWithdrawnNCT03390738Phase 2
- Avelumab Plus Carboplatin-gemcitabine in Urothelial CarcinomaCompletedNCT03390595Phase 2
- Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal CarcinomaCompletedNCT03389295Phase 2
- Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib TreatmentCompletedNCT03389126Phase 2
- Radiotherapy Dose Escalation in Locally Advanced Squamous Cell Carcinoma of the Larynx or HypopharynxWithdrawnNCT03388931Phase 4
- PLD Combined With Cisplatin in the Treatment of Advanced Poorly Differentiated Thyroid CarcinomaStatus unknownNCT03387943Phase 2
- Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell CarcinomaStatus unknownNCT03387904Phase 2
- Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapyCompletedNCT03387761Phase 1
- CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomasTerminatedNCT03387592Phase 2
- Nivolumab and Bevacizumab in Patients With Advanced and or Metastatic Hepatocellular CarcinomaTerminatedNCT03382886Phase 1
- A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCCCompletedNCT03380130Phase 2
- HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma PatientsCompletedNCT03379844Phase 2
- A Prospective Study of Molecular Detection of Salvageable Early Recurrent Nasopharyngeal Carcinoma After RadiotherapyCompletedNCT03379610
- Testosterone in Metastatic Renal Cell Carcinoma PatientsCompletedNCT03379012Phase 2
- Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal CancerStatus unknownNCT03377400Phase 2
- Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch TechniqueCompletedNCT03375281Not applicable
- VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal CancerCompletedNCT03373188Phase 1
- Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer SurvivorsCompletedNCT03372720Not applicable
- How Microbes and Metabolism May Predict Skin Cancer Immunotherapy OutcomesTerminatedNCT03370861
- Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPCStatus unknownNCT03366415Phase 3
- Clinical Pharmacology of Platinum-based Hyperthermic Intraperitoneal ChemotherapyCompletedNCT03364907
- Recurrence in Buccinator Muscle Excision With the Skin Versus Without the Skin in Buccal Squamous Cell CarcinomaStatus unknownNCT03364166Not applicable
- Metabolic Signature of Healthy Lifestyle and HCCCompletedNCT03356535
- caBozantinib in cOllectiNg ductS Renal Cell cArcInomaCompletedNCT03354884Phase 2
- Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)CompletedNCT03353077Not applicable
- Avelumab Treatment in Patients With Neuroendocrine Carcinomas (NEC G3) Progressive After ChemotherapyCompletedNCT03352934Phase 2
- Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular CarcinomaTerminatedNCT03349255Phase 1
- Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCCCompletedNCT03347292Phase 1
- To Study the Feasibility and Quality of Life of Medial Group Retropharyngeal Node Sparing in Nasopharyngeal CarcinomaStatus unknownNCT03346109Not applicable
- Assessment of Bmi-1 on Protein and Molecular Levels in Oral Dysplasia and Squamous Cell Carcinoma: A Diagnostic StudyStatus unknownNCT03345966Not applicable
- Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)CompletedNCT03345810Phase 2
- A Clinical Study of Precision TACE (P-TACE) With SurefireWithdrawnNCT03345225Not applicable
- Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal CarcinomaStatus unknownNCT03344068Phase 2/3
- Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)WithdrawnNCT03342352Phase 3
- Residual Plasma Concentration of Sorafenib and Adverse Events in CHCStatus unknownNCT03340636
- Use of a Non-ICU Specialty Ward For Immediate Post-operative Management of Head and Neck Free FlapsCompletedNCT03340038Not applicable
- SBRT or TACE for Advanced HCCStatus unknownNCT03338647Phase 3
- Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular CarcinomaStatus unknownNCT03338166
- Pembrolizumab as Neoadjuvant Treatment in HCCStatus unknownNCT03337841Phase 2
- Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.TerminatedNCT03335059Phase 3
- Trial for Retractor Sponge Evaluation in Laparoscopic Colorectal SurgeryStatus unknownNCT03334383Not applicable
- Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)TerminatedNCT03333694Phase 1
- RCM to Diagnose BCC - Reflectance Confocal Microscopy to Diagnose Basal Cell CarcinomaCompletedNCT03331874
- Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer PatientsTerminatedNCT03331601Phase 2
- Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung CancerCompletedNCT03331588Phase 3
- A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in ArgentinaCompletedNCT03330886
- Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive CytologyCompletedNCT03330028Phase 1